4.6 Article

From basic mechanisms to clinical applications in heart protection, new players in cardiovascular diseases and cardiac theranostics: meeting report from the third international symposium on New frontiers in cardiovascular research''

期刊

BASIC RESEARCH IN CARDIOLOGY
卷 111, 期 6, 页码 -

出版社

SPRINGER HEIDELBERG
DOI: 10.1007/s00395-016-0586-x

关键词

Cardiomyocyte signaling pathways; Cardioprotection; Cardiovascular disease; Co-morbidities; Drug targeting; Endothelial permeability; Extracellular RNA (eRNA); Heart regeneration; Induced pluripotent stem cells; Ischemia-reperfusion injury; Lipid metabolism; MicroRNAs (miRNAs); Mitochondria; Remote ischemic conditioning

资金

  1. German Research Foundation (DFG, Bonn, Germany)
  2. Peter und Traudl Engelhorn-Stiftung'' (Weilheim, Germany)
  3. Russian Government Program for competitive growth of Kazan Federal University, Kazan (Russian Federation)
  4. Ministerio de Economia y Competitividad [SAF2013-46058-R]
  5. Comunidad de Madrid/Fondo Social Europeo [S2010/BMD-2542 Consepoc-CM'']
  6. Red de Cardiovascular [RD12/0042/0065]
  7. Deutsche Forschungsgemeinschaft (DFG) [BE 1977/9-1, SFB1123]
  8. DFG [EXC 1010]
  9. Else Kroner-Fresenius Stiftung (EKFS) [2014_A216]
  10. Danish Council for Strategic Research [11-115818]
  11. Trygfonden
  12. NovoNordisk Fonden
  13. NIH [HL075677, HL081863]
  14. Hungarian Scientific Research Fund [OTKA ANN 107803, OTKA K-105555]
  15. Interdisciplinary Centre for Clinical Research Erlangen (IZKF) [J42, F3]
  16. Emerging Fields Initiative Cell Cycle in Disease and Regeneration (CYDER)'' (Friedrich-Alexander-University Erlangen-Nurnberg)
  17. Deutsche Forschungsgemeinschaft [SFB 1039/A6]
  18. Winetech, National Research Foundation
  19. Interdisciplinary Centre for Clinical Research IZKF Aachen
  20. Medical Research Council (UK) [G1000737]
  21. Guy's and St Thomas' Charity [R060701, R100404]
  22. British Heart Foundation [TG/15/1/31518]
  23. UK Department of Health through the National Institute for Health Research Biomedical Research Centre award
  24. Khoo Postdoctoral Fellowship Award from the Estate of Tan Sri Khoo Teck Puat, Singapore [Duke-NUS-KPFA/2016/0010]
  25. German Research Foundation (Cluster of excellence REBIRTH) Grant
  26. Duke-NUS Medical School Singapore
  27. Goh foundation
  28. Singapore National Research Foundation (NRF) fellowship [NRF-NRFF2016-01]
  29. German Research Council DFG [INST 2105/24-1, SCHN 430/6-2]
  30. German Research Foundation (DFG, Bonn, Germany) [Schu843/9-1]
  31. National Medical Research Council [NMRC/BNIG/1074/2012]
  32. Goh Foundation/Duke-NUS Medical School [GCR/2013/008, GCR/2013/010, GCR/2013/011]
  33. SingHealth Foundation [SHF/FG569P/2014, SHF/FG630S/2014]
  34. Biomedical Research Council Singapore [BMRC13/1/96/19/686A]
  35. Singapore National Research Foundation (NRF) Competitive Research Program [NRF-CRP-2008-02]
  36. Cardiometabolic Board of the Biomedical Research Centre at UCL
  37. NIHR UK
  38. Grants-in-Aid for Scientific Research [26461133] Funding Source: KAKEN
  39. British Heart Foundation [SP/12/5/29574, FS/13/2/29892, TG/15/1/31518] Funding Source: researchfish
  40. Medical Research Council [G1000737, MR/K002066/1] Funding Source: researchfish
  41. National Institute for Health Research [NF-SI-0510-10164] Funding Source: researchfish
  42. Rosetrees Trust [M274] Funding Source: researchfish
  43. MRC [G1000737, MR/K002066/1] Funding Source: UKRI

向作者/读者索取更多资源

In this meeting report, particularly addressing the topic of protection of the cardiovascular system from ischemia/reperfusion injury, highlights are presented that relate to conditioning strategies of the heart with respect to molecular mechanisms and outcome in patients' cohorts, the influence of co-morbidities and medications, as well as the contribution of innate immune reactions in cardioprotection. Moreover, developmental or systems biology approaches bear great potential in systematically uncovering unexpected components involved in ischemiareperfusion injury or heart regeneration. Based on the characterization of particular platelet integrins, mitochondrial redox-linked proteins, or lipid-diol compounds in cardiovascular diseases, their targeting by newly developed theranostics and technologies opens new avenues for diagnosis and therapy of myocardial infarction to improve the patients' outcome.

作者

我是这篇论文的作者
点击您的名字以认领此论文并将其添加到您的个人资料中。

评论

主要评分

4.6
评分不足

次要评分

新颖性
-
重要性
-
科学严谨性
-
评价这篇论文

推荐

暂无数据
暂无数据